Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1256 (LINC01256)

Target
LINC01256
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA, Other (non-coding RNA family)
01

Overview

Long intergenic non-protein coding RNA 1256 (LINC01256) is an autonomously transcribed, non-coding RNA longer than 200 nucleotides that does not overlap with protein-coding genes[1][3]. It belongs to the class of lincRNAs, which generally regulate gene expression at the transcriptional, chromatin, and RNA processing levels and are often nuclear localized[3]. These RNAs typically fine-tune expression of neighboring genes with tissue specificity and can play roles in genome organization, but there is currently no well-characterized, direct biological or disease-related function assigned to LINC01256 specifically[1][3]. LINC01256 is not classified as a therapeutically actionable target, nor has it been reported as a clinically relevant biomarker or drug target.

Other names
TCONS_l2_00021715LINC01256
02

Biological functions

RNA-mediated gene expression regulation (general lincRNA property)Chromatin remodeling (as observed for lincRNAs as a group)Transcription regulation (as observed for lincRNAs collectively)RNA stabilization (lincRNA property)
03

Disease associations

Other (no direct or specific disease involvement is reported for LINC01256 itself; some lincRNAs are involved in cancer and other diseases collectively)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1256 (LINC01256).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1256 (LINC01256).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call